Ledger.Open graph →
SEC Form D · Amendment · filed June 30, 2016

Checkmate Pharmaceuticals, Inc

Offering
$20.0M
Sold
$20.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Michael A. Powell · Cambridge, MADirectorArthur A. Krieg · Cambridge, MAExec · DirectorChuck A. Abdalian · Cambridge, MAExecCorey A. Goodman · Cambridge, MADirectorArthur A. Krieg · Cambridge, MAExec · DirectorJean A. Pineault · Colorado Springs, CODirectorJohn A. Gloriod · Colorado Springs, CODirectorRandall H. Guthrie · Colorado Springs, COExecBryan Frisina · ALISO VIEJO, CAExec · DirectorDean P. Stull · Colorado Springs, COExecMichael K. Germino · New York, NYDirectorScott K. Bessent · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗